John Carney covers Wall Street and finance for CNBC.com, where he runs NetNet, the go-to blog to get the low-down and the high jinks of Wall Street.
Carney joined CNBC in 2010 after serving as managing editor of Business Insider's Wall Street and economics section. Prior to that he was editor in chief of DealBreaker.com, a Wall Street online tabloid.
His writing has appeared in The Wall Street Journal, The New York Times, The New York Sun, Page Six Magazine, the New York Post, Fortune, Gawker and New York magazine.
He is a frequent guest on CNBC's "Power Lunch" and public radio′s "Marketplace." His writing often takes controversial positions on business topics. He has argued, for example, that failed banks should not be bailed out, that Lehman′s collapse was not a disaster and that insider trading should be legal.
Carney received a law degree from the University of Pennsylvania and practiced corporate law at firms such as Skadden, Arps, Slate, Meagher & Flom and Latham & Watkins. He primarily represented banks, hedge funds and private equity firms.
Follow John Carney on Twitter @Carney.
Maybe it was the martini that helped Carl Icahn publicly support longtime nemesis Bill Ackman.
Stocks of SunEdison and Conn's jumped Tuesday on news that Greenlight Capital had opened new positions in them.
Happy Wednesday and welcome to the Morning Six-Pack, where we're always trying to beat analyst estimates.
Hedge fund managers like Eton Park and Eclectica are still bullish on Japan despite a painful start to the year.
Bill Ackman also tells CNBC that Allergan's poison-pill defense doesn't make his takeover bid more difficult.
The bull market is seeing the equivalent of its first gray hairs and the proof is in Tuesday's blast of merger activity.
Greenlight Capital supports the subject of the book 'Flash Boys' and thinks investors should consider routing orders there.